Market Tracker

09/02 6:05pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

26.61
Data as of Sep 02
 +2.63 / +10.97%
Today’s Change
15.64
Today|||52-Week Range
32.00
+6.48%
Year-to-Date

Today’s Trading

Previous close23.98
Today’s open26.76
Day’s range25.20 - 27.12
Volume5,953,826
Average volume (3 months)1,071,574
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)-96.36%
Earnings growth (next 5 years)--
Revenue growth (last year)-76.67%
P/E ratioNM
Price/Sales1,870.76
Price/Book11.99

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc-0.75-2.07%
WXWuXi Pharmatech (Cay...+0.23+0.62%
THRXTheravance Inc-0.67-2.84%
MNKDMannkind Corp-0.15-2.04%
Data as of 4:03pm ET, 09/02/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.1M
Annual profit (last year)-$37.9M
Net profit margin-3,314.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts